Literature DB >> 30369762

Allele Specific PCR: A Cost Effective Screening Method for MPL Mutations in Myeloproliferative Neoplasms.

Arun Kumar Arunachalam1, Hemamalini Suresh1, Vikram Mathews1, Poonkuzhali Balasubramanian1.   

Abstract

Entities:  

Year:  2018        PMID： 30369762      PMCID： PMC6186221          DOI： 10.1007/s12288-018-0982-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  7 in total

1.  Detection of MPL mutations by a novel allele-specific PCR-based strategy.

Authors:  Larissa V Furtado; Helmut C Weigelin; Kojo S J Elenitoba-Johnson; Bryan L Betz
Journal:  J Mol Diagn       Date:  2013-08-28       Impact factor: 5.568

2.  Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

Authors:  Elaine M Boyd; Anthony J Bench; Andrea Goday-Fernández; Shubha Anand; Krishna J Vaghela; Phillip Beer; Mike A Scott; David Bareford; Anthony R Green; Brian Huntly; Wendy N Erber
Journal:  Br J Haematol       Date:  2010-02-11       Impact factor: 6.998

3.  MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

Authors:  Animesh D Pardanani; Ross L Levine; Terra Lasho; Yana Pikman; Ruben A Mesa; Martha Wadleigh; David P Steensma; Michelle A Elliott; Alexandra P Wolanskyj; William J Hogan; Rebecca F McClure; Mark R Litzow; D Gary Gilliland; Ayalew Tefferi
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

Review 4.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

5.  Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

Authors:  H Alchalby; A Badbaran; O Bock; B Fehse; U Bacher; A R Zander; N Kröger
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

6.  MPLW515L mutation in acute megakaryoblastic leukaemia.

Authors:  K Hussein; O Bock; K Theophile; K Schulz-Bischof; A Porwit; J Schlue; D Jonigk; H Kreipe
Journal:  Leukemia       Date:  2009-02-05       Impact factor: 11.528

7.  MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Authors:  Yana Pikman; Benjamin H Lee; Thomas Mercher; Elizabeth McDowell; Benjamin L Ebert; Maricel Gozo; Adam Cuker; Gerlinde Wernig; Sandra Moore; Ilene Galinsky; Daniel J DeAngelo; Jennifer J Clark; Stephanie J Lee; Todd R Golub; Martha Wadleigh; D Gary Gilliland; Ross L Levine
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069
  7 in total
  2 in total

1.  Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms.

Authors:  Steffen Koschmieder; Nicolas Chatain; Milena Kalmer; Kristina Pannen; Rebecca Lemanzyk; Chiara Wirths; Julian Baumeister; Angela Maurer; Kim Kricheldorf; Joelle Schifflers; Deniz Gezer; Susanne Isfort; Tim H Brümmendorf
Journal:  Ann Hematol       Date:  2022-10-21       Impact factor: 4.030

2.  Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.

Authors:  Arun Kumar Arunachalam; Madhavi Maddali; Fouzia N Aboobacker; Anu Korula; Biju George; Vikram Mathews; Eunice Sindhuvi Edison
Journal:  J Clin Immunol       Date:  2020-11-23       Impact factor: 8.317
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.